Intuitive Surgical, Inc. $ISRG Stock Sold by Pictet Asset Management Holding SA

Key Points

• Pictet Asset Management cut its Intuitive Surgical stake by 5.3% in the third quarter, selling 72,994 shares; it still held about 1.30 million shares valued at $530.3 million.
• Intuitive Surgical reported quarterly EPS of $3.00, beating the $2.65 consensus, while revenue rose 21.7% year over year to $3.05 billion. Da Vinci system placements also increased 28% year over year to 546, though analysts cautioned that some growth may reflect multi-system orders and upgrades.
• Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and an average price target of $493.54. Company insiders sold shares in recent months, while 83.64% of the stock is held by institutions and hedge funds.

Pictet Asset Management Holding SA decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,303,931 shares of the medical equipment provider's stock after selling 72,994 shares during the period. Pictet Asset Management Holding SA owned 0.38% of Intuitive Surgical worth $530,265,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Bank of America Corp DE boosted its holdings in Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock worth $1,667,388,000 after acquiring an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $1,335,753,000. Amundi grew its position in Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider's stock valued at $769,948,000 after purchasing an additional 184,044 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 61 shares of the business's stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $441.60, for a total transaction of $26,937.60. Following the sale, the executive vice president directly owned 581 shares of the company's stock, valued at $256,569.60. The trade was a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the sale, the vice president owned 1,026 shares in the company, valued at $464,993.46. The trade was a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 49,928 shares of company stock valued at $21,917,367 over the last ninety days. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ISRG shares. Zacks Research raised shares of Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a research report on Thursday, October 22nd. BNP Paribas Exane upgraded Intuitive Surgical to an "outperform" rating in a research note on Tuesday, July 28th. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. TD Cowen reiterated a "buy" rating and set a $485.00 target price on shares of Intuitive Surgical in a research report on Monday, October 19th. Finally, Piper Sandler reaffirmed an "overweight" rating on shares of Intuitive Surgical in a report on Friday, August 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $493.54.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $452.80 on Friday. The business has a 50 day simple moving average of $409.93 and a two-hundred day simple moving average of $431.89. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock has a market capitalization of $156.96 billion, a PE ratio of 54.75, a P/E/G ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to analysts' expectations of $2.91 billion. During the same quarter in the previous year, the business posted $2.40 earnings per share. Intuitive Surgical's quarterly revenue was up 21.7% on a year-over-year basis. On average, analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.